Department of Defense Opioid Prescriber Safety Training Program
- First review the “Department of Defense Opioid Prescriber Safety Training Program (OPST)” video trainings, complete posttest, etc. in Joint Knowledge Online (JKO). The OPST course number is 1176. (https://jkodirect.jten.mil/Atlas2/page/login/Login.jsf ).
- At the completion/end of the OPST course in JKO, you will receive “How to Obtain CE” information including an access code.
- Return to this site https://www.dhaj7-cepo.net/, search the catalog for the OPST course, and enter that access code to complete the requirements to obtain CE/CME credit.
- For CE/CME related questions, support, or accommodations please feel free to contact us at: firstname.lastname@example.org
The Department of Defense (DoD) Opioid Prescriber Safety Training Program stems from the presidential memo, "Addressing Prescription Drug Abuse and Heroin Use," from October 2015 that mandated training for all providers, residents, and clinical trainees in federal health care facilities who prescribe controlled substances. The memo is accessible at http://go.wh.gov/QyMgQT. It was created by tri-service experts and equips providers to improve patient outcomes for substance use disorders and pain management.
This program was developed in 2020 as an update to the previous 2016 DoD Opioid Prescriber Safety Training Program.
This activity provides continuing education for physicians, nurses, physician assistants, pharmacists, pharmacy technicians, and dentists. A certificate of attendance is available for other attendees.
- Explain the historical background that influenced the development of Opioid Prescriber Safety Training (OPST).
- Comprehend the importance of the OPST by reviewing outcome data.
- Analyze the Military Health System (MHS) Opioid Prescribing Trends.
- Summarize ways to collaborate with patients to create pain treatment goals that are achievable and relevant to the patient.
- Analyze how to refer and connect appropriate patients with chronic and acute pain for cognitive behavioral therapy for pain.
- Recognize indications for prescribing naloxone to patients.
- Comprehend the substance use disorders (SUDs) and other Behavioral Health (BH) comorbidities that occur when managing pain, the available psychotherapies, and Medication Assisted Treatments (MATs) available within DoD upon referral.
- Recognize the misuse potential and BH related problems that may occur when prescribing controlled substances including overdose, accidental death, and suicide.
- Identify potential Substance Use and Opioid Use Disorders (OUDs).
- List opioid risk mitigation recommendations and increase use of risk mitigation tools and resources.
- Explain key components of the Opioid Overdose Education and Naloxone Distribution (OEND) efforts to increase availability to naloxone to patients at risk.
- Comprehend when an active duty beneficiary’s controlled substance prescription will expire according to the new DoDI 1010.16.
- Compare opioid safety and naloxone prescribing tools in CarePoint.
OPST Resource Document
Below is a link to view and download the OPST Resource Document, which contains links to emails, websites, documents, and articles referenced in the training.
- 2.00 AAPADHA J-7 CEPO has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.00 hours of AAPA Category 1 CME credits. Physician assistants should only claim credit commensurate with the extent of their participation.
- 2.00 ACCME Non-Physician CME CreditDHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 2.00 hours for completing this Internet Activity Enduring Material activity.
- 2.00 ACPE PharmacistUAN JA4008136-0000-22-051-04-P
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 2.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
- 2.00 ACPE Pharmacy technicianUAN JA4008136-0000-22-051-04-T
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 2.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
- 2.00 ADA
- 2.00 AMA PRA Category 1 Credit™DHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. DHA J-7 CEPO designated this Internet Activity Enduring Material activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 2.00 ANCCThe DHA, J-7, CEPO is accredited by the Joint Accreditation/ Interprofessional Continuing Education (IPCE) to provide this Continuing Nursing Education Internet Activity Enduring Material for a maximum of 2.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
- 2.00 Certificate of Attendance
- 2.00 IPCEThis activity was planned by and for the healthcare team, and learners can receive up to 2.00 Interprofessional Continuing Education (IPCE) credits for learning and change. In support of improving patient care, this activity has been planned and implemented by DHA, J-7, CEPO. DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the Association of Regulatory Boards of Optometry's Council on Optometric Practitioner Education (ARBO/COPE), the Association of Social Work Boards (ASWB), the American Psychological Association (APA), the American Dental Association’s Continuing Education Recognition Program (ADA CERP), and Commission on Dietetic Registration (CDR) to provide continuing education for the health care team.